Popular Articles

FDA Approves Boston Scientific's TAXUS(R) Liberte(R) Long Stent
Boston Scientific Corporation (NYSE: BSX) announced it has received approval from the U.S. Food and Drug Administration (FDA) to market its TAXUS((R)) Liberte((R)) Long Paclitaxel-Eluting Coronary Stent System, a next-generation drug-eluting stent (DES) designed for long lesions. At 38 mm, it is the longest available DES, providing doctors an option that can potentially reduce the number of stents used in more complex cases, simplifying procedures and reducing costs. It affords a more efficient treatment option for the estimated 8 to 10 percent(1) of patients with long lesions. The Company plans to launch the product in the U.S. next month. It received CE Mark approval in 2007.

Today's Selection Of Opinions And Editorials
Health Co-ops Emerge As Weak Substitute USA Today
News of the day
Iowa's Criminal HIV Transmission Law Examined
A recent court decision in Black Hawk County, Iowa where a 34-year-old HIV-positive man was sentenced to 25 years in prison and a lifetime of parole for not informing a sexual partner of his status, might lead to a national discussion on state criminal transmission laws, the Iowa Independent reports. Nick Clayton Rhoades pleaded guilty to criminal transmission of HIV, a felony in Iowa, although he did not transmit the virus to his partner. Under state law, "in direct contradiction to its formal title," transmission is not required for a person to be prosecuted - engaging in activity that intentionally exposes others to the body fluids of an infected person could result in prosecution, including kissing, according to the Independent. Some say that such unintended consequences might encourage Iowa and other states to revisit their transmission laws, the article states (Waddington, Iowa Independent, 6/29).
Endocrinology

Close Relationship With Caregivers Slows Alzheimer's

A group of Utah State University researchers and colleagues at Johns Hopkins University, Duke University and Boston University have demonstrated that the rate of clinical progression of dementia may be slowed by a close relationship with one"s caregiver. The findings will be published in the September 2009 issue of "The Journals of Gerontology Series B: Psychological Sciences and Social Sciences" by Oxford Journals The research study "Caregiver Recipient Closeness and Symptom Progression in Alzheimer Disease. The Cache County Dementia Progression Study," started in 2002 and monitored 167 participants with Alzheimer"s disease for three years. The study, funded by the National Institutes of Health, measured the cognitive and functional status of the participants and the caregiver-reported relationship of the participants. It was found that higher levels of closeness to ones caregiver were significantly associated with a slower decline in both cognitive and functional domains, especially in persons with spouse caregivers. USU Researchers involved in the study are Maria Norton, associate professor of family, consumer and human development and principal investigator for the Cache County Memory Study, the population wide project from which persons with dementia were identified; JoAnn Tschanz, associate professor of psychology and director of the Cache County Dementia Progression Study; and Kathy Piercy, associate professor of family, consumer and human development; and Chris Corcoran, associate professor of mathematics and statistics. "This is the first study to demonstrate that, in addition to medications that help slow the progression of the disease, there are non-pharmacologic factors in the caregiving environment that may also help to extend functional abilities and quality of life for the person with dementia," Norton said. "Considering the aging of the "Baby Boomer" generation, finding ways to reduce risk for development of dementia and slowing the rate of decline in affected individuals are urgent public health priorities." The researchers will now focus on finding the kind of caregiver activities that may promote the longevity and quality of brain function for those suffering from dementia. The new focus may lead to interventions that will enhance the caregiving relationship and help slow the decline caused by Alzheimer"s disease. USU has collaborated with Duke University and Johns Hopkins University since 1994 when it began the Cache County Memory Study. The study is funded by the National Institute on Aging and has followed an initial cohort of more than 5,000 persons aged 65 and older to study the genetic and environmental factors that affect risk for development of Alzheimer"s Disease and other dementias. Persons identified with dementia by the Cache County Memory Study are then monitored by the Cache County Dementia Progression Study. The Cache County Memory Study follows individuals to the point of dementia onset to study what factors affect risk of developing the disease. The Dementia Progression Study is focused on what factors affect the rate of progression of the disease once it has started. "The extraordinary participation rate (90 percent of the entire eligible population) and unusual longevity of the population in Cache County, Utah (the U.S. county with the highest longevity, based on 1990 Census), have made our university and its setting an ideal place for such a large-scale epidemiologic study," Norton said. Norton has been involved in managing the study since its inception in 1994 and has been the local director of the project since 2001. Utah State University


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):